Last reviewed · How we verify
NCT03443102
Long-term Assessment of Organ Functions Among Survivors of Severe Acute Respiratory Syndrome
trial in SARS Virus in 150 participants. Status unknown.
1 July 2018
Quick facts
| Lead sponsor | Peking University People's Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 25 January 2018 |
| Primary completion | 1 July 2018 |
| Estimated completion | 1 December 2018 |
| Sites | 1 location across China |
Conditions studied
- SARS Virus — all drugs for SARS Virus →
- Long-Term Survivors — all drugs for Long-Term Survivors →
Sponsor
Peking University People's Hospital
Who can join
Eligibility, any sex, with SARS Virus or Long-Term Survivors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
SARS-CoV has caused severe epidemic respiratory disease in human populations. By July 2003, a total of 8,096 probable cases of SARS had been reported including 774 deaths in 27 countries, around one-third of which were health care workers (HCWs). Previous studies have been reported about long-term impacts of SARS infection, including lung function deficiency, steroid-induced osteonecrosis, reduced exercise capacity, and impairment in health-related quality of life (HRQoL). HCWs, especially nurses, have been reported to experience greater psychological distress, particularly increased levels of posttraumatic stress symptomatology (PTSS). But the very complex impacts of this fatal infection on HCWs have not been fully elucidated. It is thus important to follow these occupational patients to detect and manage multi-organ sequelae and functional impairment.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study.
Zhang P, Li J, Liu H, Han N, et al · · 2020 · cited 315× · PMID 32128276 · DOI 10.1038/s41413-020-0084-5 -
Investigation of the impact of SARS-CoV infection on the immunologic status and lung function after 15 years.
Li J, Zheng Y, Zhao L, Yue Z, et al · · 2021 · cited 4× · PMID 34819019 · DOI 10.1186/s12879-021-06881-3 -
Investigation of the Impact of SARS-CoV-1 Infection on the Immunologic Status and Lung Function After 15 Years
Li J, Zheng Y, Zhao L, Yue Z, et al · · 2021 · DOI 10.21203/rs.3.rs-386485/v1 -
Long-term consequences in lung and bone associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study
Zhang P, Li J, Han N, Liu H, et al · · 2018
Verify or expand the search:
- PubMed search for NCT03443102
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Peking University People's Hospital trials
Trials by the same sponsor.
- NCT07535645 — Baricitinib for Post-HSCT Persistent Thrombocytopenia · Phase 1, PHASE2 · not yet recruiting
- NCT07516002 — Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency · not yet recruiting
- NCT07294339 — A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positiv · NA · not yet recruiting
- NCT07500441 — Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML · recruiting
- NCT07487883 — Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03443102 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University People's Hospital
- Last refreshed: 26 February 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03443102.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing